[HTML][HTML] Optimal respiratory syncytial virus intervention programmes using nirsevimab in England and Wales

D Hodgson, M Koltai, F Krauer, S Flasche, M Jit… - Vaccine, 2022 - Elsevier
Abstract Introduction Respiratory Syncytial Virus (RSV) is a major cause of acute lower
respiratory tract infections (ALRI) in infants. There are no licensed vaccines and only one …

[HTML][HTML] Predicting the impact of COVID-19 non-pharmaceutical intervention on short-and medium-term dynamics of enterovirus D68 in the US

SW Park, K Messacar, DC Douek, AB Spaulding… - Epidemics, 2024 - Elsevier
Recent outbreaks of enterovirus D68 (EV-D68) infections, and their causal linkage with
acute flaccid myelitis (AFM), continue to pose a serious public health concern. During 2020 …